Legend Biotech (LEGN) Change in Taxes (2020 - 2026)
Legend Biotech's (LEGN) quarterly Change in Taxes came in at -$2.1 million in Q3 2025, down 4093.88% YoY from $51453.8 in Q3 2024, and down 4093.88% on a QoQ basis from -$49000.0 in Q3 2024.
Analysis
Legend Biotech (LEGN) Change in Taxes (2020 - 2026) Analysis & Trends
Legend Biotech (LEGN) has 5 years of Change in Taxes data on file, last reported at -$2.1 million in Q3 2025.
- Quarterly Change in Taxes fell 4093.88% year-over-year to -$2.1 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was -$3.0 million (down 229.35% YoY) and the FY2022 annual result came in at $3.7 million, up 565.89% from the prior year.
- Change in Taxes retreated to -$2.1 million in Q3 2025, from -$49000.0 in the prior quarter.
- In the past five years, Change in Taxes ranged from a high of $3.7 million in Q4 2022 to a low of -$2.1 million in Q3 2025.
- A 4-year average of $219166.7 and a median of $11000.0 in 2024 frame the typical range for Change in Taxes.
- Annual changes were most pronounced in 2022 — Change in Taxes jumped 565.89% — and 2025, when it tumbled 4093.88%.
- Tracing LEGN's Change in Taxes over 4 years: stood at $557000.0 in 2021, then jumped by 565.89% to $3.7 million in 2022, then slumped by 101.32% to -$49000.0 in 2024, then plunged by 4093.88% to -$2.1 million in 2025.
- The last three Change in Taxes figures came in at -$2.1 million (Q3 2025), -$49000.0 (Q3 2024), and -$918000.0 (Q2 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Legend Biotech | 3.97 Bn | 3.00 Bn | 251.50 Mn | -9.30 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -9.30 Mn |
| Mar 31, 2026 | -200,000.00 |
| Dec 31, 2025 | -1.18 Mn |
| Sep 30, 2025 | -2.02 Mn |
| Jun 30, 2025 | -3.30 Mn |
| Mar 31, 2025 | -11.90 Mn |
| Dec 31, 2024 | -704,000.00 |
| Sep 30, 2024 | -49,000.00 |
| Jun 30, 2024 | -918,000.00 |
| Mar 31, 2024 | 71,000.00 |
| Dec 31, 2023 | -700,000.00 |
| Dec 31, 2022 | 3.71 Mn |
| Dec 31, 2021 | 557,000.00 |
| Dec 31, 2020 | -278,000.00 |